Influência das mídias sociais na automedicação na pandemia da COVID-19
Influence of social media on self medication in the COVID-19
DOI:
https://doi.org/10.13102/rscdauefs.v12i1.6200Keywords:
Self-medication, COVID-19, Social Media, RiskAbstract
In the current context, the media, such as the internet, disseminate information on studies of experimental treatments for COVID-19, triggering self-medication. The objective was to present the influence of social media against self-measurement during the COVID-19 pandemic. This is a literature review, carried out in the databases: SciELO and PubMed, using the descriptors: Fake News, Self-medicine, COVID-19, Social media and Risk, combined by the Boolean operator “AND”. Publications between January and June 2020 were selected in English. It was found that social media is configured as a source of information information during the pandemic. The population obtains knowledge about therapies, from digital media, favoring self-medication. Measures such as monitoring information shared on the networks and greater caution by professionals when disseminating findings are essential to minimize the risks caused by self-medication.
Downloads
Metrics
References
Ahmed W, Vidal-Alaball J, Downing J, López Seguí F. COVID-19 and the 5G Conspiracy Theory: Social Network Analysis of Twitter Data. J Med Internet Res 2020; 22(5):e19458.
Rovetta A, Bhagavathula AS. COVID-19-Related Web Search Behaviors and Infodemic Attitudes in Italy: Infodemiological Study. JMIR Public Health Surveill 2020;6(2): e19374.
Naeem SB, Bhatti R, Khan A. An exploration of how fake news is taking over social media and putting public health at risk. Health Info Libr Journal 2020; 38(2): 143-49.
Ahmad AR, Murad HR. The Impact of Social Media on Panic During the COVID-19 Pandemic in Iraqi Kurdistan: Online Questionnaire Study. J Med Internet Res 2020; 22(5): e19556.
Menuci JM, Ferreira LP, Menegat IC. A influência da mídia no processo penal. Temática 2016; 12(1):170-184.
Inocencio LE, Martins LL. Reflexos no espelho do capitalismo: o caráter narcisista do consumo emoldurado pela persuasão do discurso publicitário. Temática 2011; 7(11): 1-11.
Tapia L. COVID-19 and Fake News in the Dominican Republic. Am J Trop Med Hyg 2020; 102(6): 1172-1174.
Abd-Alrazaq A, Alhuwail D, Househ M, Hamdi M, Shah Z. Top Concerns of Tweeters During the COVID-19 Pandemic: Infoveillance Study. J Med Internet Res 2020; 21;22(4):e19016.
Onchonga D. A Google Trends study on the interest in selfmedication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharm J 2020; 28(7):903-904.
Moritz K, Seiberth JM, Schiek S, Bertsche T. The impact of evidence from clinical trials on counselling for over-the-counter drugs: A national survey of pharmaceutical staff in German pharmacies. J Clin Pharm Ther 2019; 44(6):895-903.
Larrouquere L, Gabin M, Poingt E, Mouffak A, Hlavaty A, Lepelley M, et al. Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic. Fundam Clin Pharmacol 2020; 34(3):389-396.
G1 Minas. Coronavírus: vendas de medicamentos aumentam durante a pandemia, e farmacêuticos alertam sobre o risco da automedicação [Internet]. G1 Minas Gerais, 2020. [acesso em 21 abr 2021]. Disponível em: <https://g1.globo.
com/mg/minas-gerais/noticia/2020/05/04/coronavirusvendas-de-medicamentos-aumentam-durante-a-pandemia-campanha-alerta-sobre-o-risco-da-automedicacao.ghtml>.
Agência Nacional de Vigilância Sanitária (BR). Ivermectina e Nitazoxanida: volta a receita em uma via [Internet]. Brasília: ANVISA; 2020. [acesso em 21 abr 2021]. Disponível em: <http://antigo.anvisa.gov.br/en_US/ noticias/-/asset_publisher/FXrpx9qY7FbU/content/ivermectinae-nitazoxanida-voltam-a-receita-em-uma-via/219201?inheritRedirect=false&redirect=http%3A%2F%2Fantigo.anvisa.gov.br%2Fen_US%2Fnoticias%3Fp_p_id%3D101_INSTANCE_FXrpx9qY7FbU%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3Dcolumn-2%26p_p_col_count%3D1%26p_r_p_564233524_tag%3Ddicol>.
Druml C. COVID-19 and ethical preparedness. Wien Klin Wochenschr 2020; 132(13-14):400-402.
Naeem SB, Bhatti R. The Covid-19 ‘infodemic’: a new front for information professionals. Health Info Libr J 2020; 37(3):233-239.
Bauer SR, Kapoor A, Rath M, Thomas SA. What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19? Cleve Clin J Med 2020; 87a.ccc046.
Conselho Federal de Farmácia (CFF). Levantamento mostra como o medo da Covid-19 impactou venda de medicamentos [Internet]. Brasília: CFF, 2020. [acesso em 10 ago 2020]. Disponível em: https://www.cff.org.br/noticia.php?id=5747.
Ministério da Saúde (BR). Conselho Nacional de Saúde. CNS alerta: medicamentos ainda em estudos contra Covid-19, sem prescrição, podem causar danos à saúde [Internet]. Brasília: MS; 2020. [acesso em 10 ago 2020]. Disponível em: http://conselho.saude.gov.br/ultimas-noticias-cns/1085-cns-alerta-medicamentos-ainda-em-estudos-contra-covid-19-sem-prescricao-podem-causar-danos-a-saude.
Wong A. COVID-19 and toxicity from potential treatments: Panacea or poison. Emergency Medicine Australasia 2020; 32(4):697-699.
Zolk O, Hafner S, Schmidt CQ, German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). Naunyn Schmiedebergs Arch Pharmacol 2020;393(7):1131-1135.
Kutti Sridharan G, Kotagiri R, Chandiramani VH, Mohan BP, Vegunta R, Vegunta R, Rokkam V. COVID-19 and avoiding ibuprofen. How good is the evidence? Am J Ther 2020; 27(4):e400-e402.
Sharma N, Landsberg E, Kumar V, Gambhir H. A Curious Case of Hypervitaminosis D. Cureus 2020; 12(6): 12(6):e8515.
Erku DA, Belachew AS, Abrha S, Sinnollareddy M, Thomas J, Steadman KJ, Tesfaye WH. When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19. Res Social Adm Pharm 2020; S1551-7411(20):30455-1.
El-Jardali F, Bou-Karroum L, Fadlallah R. Amplifying the role of knowledge translation platforms in the COVID-19 pandemic response. Health Res Policy Sys 2020; 18(1):s12961-020-00576-y.
Pashkov VM, Olefir AA, Bytyak OY. Legal features of the drug advertising kwestie prawne dotyczące reklamy produktów leczniczych. Wiad Lek 2017; 70(1):133-138.
